ABIONYX Pharma vs Enterome
ABIONYX Pharma vs Enterome, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ABIONYX Pharma is on 44/100 and Enterome on 60/100.
Where each one leads
ABIONYX Pharma
- agent readiness: 43/100 against 21/100
- funding raised: $225M against $124M
Enterome
- our overall score: 60/100 against 44/100
- domain rating: 46/100 against 25/100
At a glance
| Measure | ABIONYX Pharma | Enterome |
|---|---|---|
| What it is | Biopharmaceutical company developing innovative therapies for sepsis and intensive care. | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Drug Discovery, Oncology, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software | hardware | services | marketplace | platform |
| Founded | 2015 | 2012 |
| Headquarters | Toulouse, France | Paris, France |
| Status | Active | Active |
Size, funding and growth
| Measure | ABIONYX Pharma | Enterome |
|---|---|---|
| Employees | Not published | 33 |
| Total funding | $225M | $124M |
| Latest round | Capital Increase | Later Stage VC |
| Valuation | $1.1B | Not published |
| LinkedIn followers | Not published | 16,846 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ABIONYX Pharma | Enterome |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 60/100 |
| Traction | 40/100 | 55/100 |
| Team | 20/100 | 70/100 |
| Search visibility | 5/100 | 34/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (43/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ABIONYX Pharma | Enterome |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Jquery | Bootstrap |
| Analytics | Google Analytics 4 | Google Analytics 4, Segment |
ABIONYX Pharma vs Enterome: common questions
Which is better, ABIONYX Pharma or Enterome?
On our 0-100 score Enterome rates higher (60/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do ABIONYX Pharma and Enterome compare on the numbers?
ABIONYX Pharma leads on agent readiness (43/100 against 21/100), funding raised ($225M against $124M). Enterome leads on our overall score (60/100 against 44/100), domain rating (46/100 against 25/100).
Read the full ABIONYX Pharma review and pricing or the Enterome review and pricing. You can also browse other ABIONYX Pharma alternatives we track.